1. A multi-disciplinary approach to delivering PCSK9 inhibitor therapy – first 12 months experience at a specialist cardiothoracic centre. (August 2018) Authors: Hayes, C.; Browne, C.; Neves, E.; Breen, J.; Priestley-barnham, L.; Davis, L.; Pottle, A.; Thompson, K.; Manning, S.; Barbir, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population‐based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma. Issue 1 (5th December 2018) Authors: Latchana, N.; Davis, L.; Coburn, N. G.; Mahar, A.; Liu, Y.; Hammad, A.; Kagedan, D.; Elmi, M.; Siddiqui, M.; Earle, C. C.; Hallet, J. Journal: BJS open Issue: Volume 3:Issue 1(2019) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗